NIAID conducts and supports research to better understand, treat, and ultimately prevent infectious and immune-mediated diseases. For more than 60 years, NIAID research has led to new therapies, vaccines, diagnostic tests, and other technologies that have improved the health of millions of people in the United States and abroad. This page highlights notable scientific advances made by NIAID laboratories and NIAID-funded researchers.
This slideshow reviews selected science news highlights from 2018. NIAID researchers and NIAID-funded scientists made significant advances in understanding and treating allergic, immunologic, autoimmune and infectious diseases. Other work accelerated progress toward development of novel vaccines. In addition, NIAID issued a strategic plan to reinvigorate research on tuberculosis, the leading infectious cause of death worldwide. View the Selected NIAID Science News Highlights of 2018.
This slideshow summarizes selected science news highlights from 2017. NIAID researchers and NIAID-funded scientists made significant progress in developing vaccines and treatments for various infectious diseases, including Zika, HIV and malaria. Other discoveries yielded novel insights into rare diseases and drug-resistant infections. View the Selected NIAID Science News Highlights of 2017.